Company Filing History:
6 out of 26 
1 out of 192 
1 out of 721 
Years Active: 2000-2012
Title: Sabine Fricke: Innovator in Hormonal Therapies
Introduction
Sabine Fricke is a prominent inventor based in Jena, Germany. She has made significant contributions to the field of pharmaceutical sciences, particularly in the area of hormonal therapies. With a total of 10 patents to her name, her work focuses on methods and compositions that enhance the reliability of testosterone levels in patients.
Latest Patents
Fricke's latest patents include innovative methods and pharmaceutical compositions aimed at achieving acceptable serum testosterone levels. One notable invention describes methods for providing prolonged physiologically acceptable steady-state serum testosterone levels in patients deficient in endogenous testosterone. This includes methods for male contraception and treatments for diseases associated with low testosterone levels. Another patent focuses on pharmaceutical compositions formulated for injectable administration, specifically utilizing testosterone undecanoate in a vehicle comprising castor oil and a co-solvent. These compositions allow for reliable testosterone levels in serum over extended periods, facilitating hormone replacement therapy and male contraception without the need for continuous monitoring by a physician.
Career Highlights
Throughout her career, Sabine Fricke has worked with notable companies, including Jenapharm GmbH & Co. KG. Her expertise in pharmaceutical formulations has positioned her as a leader in her field, contributing to advancements in hormonal therapies.
Collaborations
Fricke has collaborated with esteemed colleagues, including Michael Dittgen and Michael Oettel, further enhancing her research and development efforts in the pharmaceutical industry.
Conclusion
Sabine Fricke's innovative work in hormonal therapies has made a significant impact on the medical field. Her patents reflect her dedication to improving patient care through reliable and effective treatments.